Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Evan Court
Results of collaborative atorvastatin diabetes study reported
April 26th, 2005
A researcher reports preliminary results of the collaborative atorvastatin diabetes study in a recent issue of the International Journal of Clinical Practice. "The Collaborative AtoRvastatin Diabetes Study (CARDS) is the first large primary prevention study to focus specifically on the role of a statin in patients aged 40-75 years with type 2 diabetes, but no signs or symptoms of pre-existing vascular disease and who had only average or below average cholesterol levels. The trial was a prospective double-blind randomized trial with 2,383 type 2 diabetic subjects randomized to either 10-mg atorvastatin daily or placebo. Originally designed to run for 5 years, the...
Source: Cardiovascular Business Week (2005-04-26)
|
